| Latest | F'cast | |
|---|---|---|
| Div Yield | 7.1% | 0.0% |
| Div Cover | 1.0 | 1.0 |
| Op Mrgn | 56.9% | 89.7% |
| ROCE | 0.0% |
| Latest | F'cast | |
|---|---|---|
| P/E | 14.0 | 13.5 |
| PEG | 4.8 | 3.8 |
| Pr/Revenue | 14.0 | 11.8 |
| Pr/Book | 1.8 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 7.0% | 18.2% |
| PBT | 80.1% | 310.3% |
| EPS | 2.9% | 3.6% |
| DPS | 3.0% | 3.4% |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | 139.00 | 112.40 | 5.80p | 26.3 | 4.4 | +6% | 5.90p | 3.9% |
| 31-Dec-21 | 145.60 | 141.60 | 6.20p | 24.4 | 3.5 | +7% | 6.20p | 4.1% |
| 31-Dec-22 | 154.10 | 56.90 | 6.60p | 16.8 | 2.8 | +6% | 6.50p | 5.9% |
| 31-Dec-23 | 169.80 | 26.10 | 6.80p | 15.3 | 5.1 | +3% | 6.70p | 6.5% |
| 31-Dec-24 | 181.70 | 47.00 | 7.00p | 13.3 | 4.4 | +3% | 6.90p | 7.4% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-25 | 214.86 | 192.83 | 7.25p | 13.5 | 3.8 | +4% | 7.13p | 0.0% |
| 31-Dec-26 | 293.89 | 283.41 | 7.45p | 13.1 | 4.7 | +3% | 7.32p | 0.0% |
| 31-Dec-27 | 290.31 | 281.62 | 7.75p | 12.6 | 3.1 | +4% | 7.51p | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
| Director/PDMR Shareholding | 18-Dec-2025 | 14:00 | RNS |
| Director/PDMR Shareholding | 18-Dec-2025 | 14:00 | RNS |
| Director Appointment | 02-Dec-2025 | 07:00 | RNS |
| Director/PDMR Shareholding | 18-Dec-2025 | ShareCast |
| Primary Health Properties a 'clear winner' from ... | 27-Nov-2025 | ShareCast |
| Primary Health Properties clears CMA hurdle on A... | 29-Oct-2025 | ShareCast |
| Nine property companies poised to convert to Reits | 31-Dec-2006 | Sunday Telegraph |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 97.80p |
| Change Today | 0.20p |
| % Change | 0.20 % |
| 52 Week High | 103.50 |
| 52 Week Low | 86.15 |
| Volume | 22,181,224 |
| Shares Issued | 2,595.09m |
| Market Cap | £2,538.00m |
| Beta | 0.53 |
| RiskGrade | 84 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 5 |
| Buy | 3 |
| Neutral | 2 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 10 |

| Latest | Previous | |
|---|---|---|
| Q4 | Q3 | |
| Ex-Div | 09-Oct-25 | 03-Jul-25 |
| Paid | 21-Nov-25 | 15-Aug-25 |
| Amount | 1.77p | 1.77p |
| Time | Volume / Share Price |
| 16:49 | 44 @ 97.80p |
| 16:47 | 33,354 @ 97.80p |
| 16:47 | 88,524 @ 97.80p |
| 16:46 | 19,686 @ 97.80p |
| 16:45 | 1,028 @ 97.80p |
| CFO | Richard Howell |
| CEO | Mark Davies |
You are here: research